Pfizer Inc. Insider Trading

PFE

Cluster buy

3 insiders bought $2.96M of their own stock in 8 days.

Open-market purchases by executives and directors between Aug 5 and Aug 12. Buying is rarer than selling and says more, but it is one input, not a verdict.

Net open-market

+$2.83M

3 buys · 2 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

3 / 1

executives and directors

Last open-market buy

Aug 2026

Aug 12, 2026

Get an email when PFE's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 12	Albert Bourla Chairman & CEO	Bought	38,000	$26.34	$1M	9.6%	Form 4
Aug 5	Jennifer B. Damico SVP & Controller	SoldNo plan	3,278	$25.40	83K	10%	Form 4
Aug 5	Ronald E Blaylock Director	Bought	39,231	$25.46	999K	121%	Form 4
Aug 5	Mortimer J Buckley Director	Bought	37,632	$25.52	960K	New	Form 4
Jun 9	Jennifer B. Damico SVP & Controller	SoldNo plan	2,000	$25.70	51K	6.0%	Form 4
Mar 4, 2025	Jennifer B. Damico SVP & Controller	SoldNo plan	2,500	$25.93	65K	17%	Form 4
Feb 13, 2025	Ronald E Blaylock Director	Bought	19,457	$25.65	499K	150%	Form 4

Aug 12
Albert Bourla
Chairman & CEO · bought 38,000 at $26.34
$1M
9.6% of stake
Aug 5No plan
Jennifer B. Damico
SVP & Controller · sold 3,278 at $25.40
83K
10% of stake
Aug 5
Ronald E Blaylock
Director · bought 39,231 at $25.46
999K
121% of stake
Aug 5
Mortimer J Buckley
Director · bought 37,632 at $25.52
960K
New position
Jun 9No plan
Jennifer B. Damico
SVP & Controller · sold 2,000 at $25.70
51K
6.0% of stake
Mar 4, 2025No plan
Jennifer B. Damico
SVP & Controller · sold 2,500 at $25.93
65K
17% of stake
Feb 13, 2025
Ronald E Blaylock
Director · bought 19,457 at $25.65
499K
150% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PFE, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with PFE

CompareIntrinsic value

ABBVAbbVie Inc.

$294.83+3.09%49

MRKMerck & Co., Inc.

$150.36+3.93%41

BMYBristol-Myers Squibb Company

$64.20+4.04%61

ABTAbbott Laboratories

$115.55+5.62%25

LLYEli Lilly and Company

$1,418.07+0.62%73

JNJJohnson & Johnson

$276.34+3.82%53

UPCUniverse Pharmaceuticals Inc.

$1.47-1.34%39

TEVATeva Pharmaceutical Industries Ltd

$42.13+0.52%46

Held by ETFs

PFE is in 356 US ETFs. The largest of them, with PFE's weight in each:

Spot a number that looks wrong? Check it in PFE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PFE

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.